论文信息 - A bacteriophage journey at the European Medicines Agency

A bacteriophage journey at the European Medicines Agency

The seriously and globally increasing bacterial multi-drug resistance calls out on concerted counteractive measures: international health authorities give consideration to the therapeutical use of bacteriophage therapy.

[1] M. Witzenrath. Time for tailored antimicrobials: adapted bacteriophages in the ICU. , 2015, Critical care medicine.

[2] S. Abedon,et al. Re-establishing a place for phage therapy in western medicine. , 2015, Future microbiology.

[3] A. Buckling,et al. Quality and Safety Requirements for Sustainable Phage Therapy Products , 2015, Pharmaceutical Research.

[4] W. Fortuna,et al. Clinical aspects of phage therapy. , 2012, Advances in virus research.

[5] A. Buckling,et al. The Phage Therapy Paradigm: Prêt-à-Porter or Sur-mesure? , 2011, Pharmaceutical Research.

[6] G. Volckaert,et al. Quality-Controlled Small-Scale Production of a Well-Defined Bacteriophage Cocktail for Use in Human Clinical Trials , 2009, PloS one.